FDA Panel Unanimously Backs Moderna’s COVID Vax for Kids and Teens
A committee of independent vaccine experts recommended that the FDA grant an emergency use authorization (EUA) for the two-dose Moderna COVID-19 vaccine for kids ages 6 to 17 years. The Vaccines and Related Biological Products Advisory Committee (VRBPAC) voted 22-0, agreeing unanimously that the benefits of vaccination outweigh the risks in two age groups: kids […]
Reassuring Data on Two-Dose Hep B Vaccine, Risk of Acute MI
There was no higher risk of heart attack for recipients of the two-dose hepatitis B cytosine phosphoguanine adjuvant vaccine (Heplisav-B) compared to the three-dose hepatitis B vaccine with an aluminum hydroxide adjuvant (Engerix-B), a prospective study found. Among nearly 70,000 adults who received at least one hepatitis B vaccine dose, type 1 acute myocardial infarctions […]